|Day's Range||13.20 - 13.32|
|52 Week Range||11.85 - 15.68|
|PE Ratio (TTM)||21.52|
|Earnings Date||Aug 2, 2017 - Aug 7, 2017|
|Dividend & Yield||1.24 (9.37%)|
|1y Target Est||14.69|
Hercules Capital, Inc. , the leading specialty finance company to innovative, venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, today announced the estimated accretive impact to its debt investment portfolio attributed to the Federal Reserve - Federal Open Market Committee’s increase in the federal funds rate by 25 basis points, or 0.25%.
Q1 2017 Hercules Capital Inc Earnings Call
EWING, N.J., June 07, 2017-- Antares Pharma, Inc. today announced that it has entered into a loan and security agreement for a term loan of up to $35 million, with Hercules Capital, Inc., a leader in customized ...